VanEck Developed Markets Dividend Leaders ETF shows strong ...
Roche defends profits via AI and efficiency as European ...
Roche sieht sein profitables Geschäftsmodell durch hohe ...
Roches Alzheimer-Wirkstoff Trontinemab entfernt dank Brainshuttle-Technologie ...
Europa Schluss: RĂĽckschlag nach Erholung - SMI verliert ...
Aktien Europa Schluss: RĂĽckschlag nach Erholung - SMI verliert ...
Der europäische Aktienmarkt wird Ende März 2026 von der ...
Nvidia reporta ingresos récord y anuncia retribución del ...
Roche partners with Nvidia to deploy over 3 500 AI GPUs ...
Ams Osram led the Swiss market with an 11.06% surge breaking ...
Die Schweizerische Nationalbank hält die Zinsen stabil ...
NVIDIA orchestriert den globalen Rollout der Blackwell-Architektur ...
Roche launches automated organoid institute and new diagnostic ...
Roche stärkt seine Pipeline mit einer 100-Millionen-Investition ...
Der ETF bildet die 20 bedeutendsten Schweizer Aktien physisch ...
Newron reports 2025 results extends EIB debt to 2028 and ...
Roche fĂĽhrt ein neues Diagnostiksystem fĂĽr bis zu 25 Erreger ...
Keine FĂĽhrungswechsel beim Weltwirtschaftsforum in Davos ...
Der Schweizer Aktienmarkt erholt sich von geopolitischen ...
NVIDIA positioniert sich mit einer vollständigen Plattform ...
Roche beendet die klinische Entwicklung von Emugrobart fĂĽr ...
A pesar de récords de ventas con Mounjaro y Zepbound la ...
Eli Lilly shares fall despite blockbuster Q4 results. Investors ...
Newron enters a pivotal phase with its 2025 annual report ...
BioNTech busca autorización en EE.UU. en 2026 para su fármaco ...
Der breit diversifizierte Europa-ETF verzeichnet starke ...
Roche presents promising Alzheimer s & Parkinson s data ...
Der Investment Trust setzt auf ein konzentriertes Portfolio ...
Roche reports strong Phase III lupus data for Gazyva and ...
Nvidia doubles chip revenue forecast to $1 trillion but ...
BioNTech spins off its mRNA business into a separate entity ...
BioNTech separa su unidad de ARN mensajero en una nueva ...
La revisiĂłn al alza de ingresos para sus chips de IA contrasta ...
Roche Diagnostics erhält europäische Zulassung für einen ...
EQS-HV: HELLA GmbH & Co. KGaA: Bekanntmachung der Einberufung ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarkets™ ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂŞ EDIZIONE DELL AMERICA ...
Roche receives CE mark for first IVD immunoassay blood test ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarkets™ ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂŞ EDIZIONE DELL AMERICA ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂŞ EDIZIONE DELL AMERICA ...
La Roche-Posay se une a la 38ª Copa América como socio ...
The VanEck Morningstar Developed Markets Dividend Leaders ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Viral Vectors and Plasmid DNA Manufacturing Market to Reach ...
LA ROCHE-POSAY PARTECIPA ALLA 38ÂŞ EDIZIONE DELL AMERICA ...
Roche receives CE mark for first IVD immunoassay blood test ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarkets™ ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
LA ROCHE-POSAY JOINS THE 38TH AMERICA'S CUP AS TITLE PARTNER ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
La Roche-Posay se une a la 38ª Copa América como socio ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Roche receives CE mark for first IVD immunoassay blood test ...
Chemiluminescence Immunoassay Market worth $16.39 billion ...
Viral Vectors and Plasmid DNA Manufacturing Market to Reach ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Tissue Diagnostics Market worth $10.86 billion by 2030 | ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
Microfluidics Market worth $37.2 billion by 2030 | MarketsandMarkets™ ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
Checkpoint Inhibitor Refractory Cancer Drugs Market to Reach ...
Tissue Diagnostics Market worth $10.86 billion by 2030 | ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
LA ROCHE-POSAY REJOINT LA 38EME AMERICA S CUP EN TANT QUE PARTENAIRE TITRE DE L ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarkets™ ...
Insulin Delivery Devices Market: 7.82% CAGR to 2031 Driven ...
Roche receives CE mark for first IVD immunoassay blood test ...
Microfluidics Market to Reach $77.5 Billion Globally by ...
Drug Screening Market worth $21.29 billion by 2030 | MarketsandMarkets™ ...
Viral Vectors and Plasmid DNA Manufacturing Market to Reach ...
Roche receives CE mark for first IVD immunoassay blood test ...
Microfluidics Market worth $37.2 billion by 2030 | MarketsandMarkets™ ...
Growth Factors Market to Reach US$ 3.7 Bn by 2033 Expands ...
Drug Abuse Testing Market to Reach $8.9 billion Globally ...
Los fundadores de BioNTech anuncian su salida para 2026 ...